Last reviewed · How we verify
Placebo for hydrocortisone
Placebo for hydrocortisone is a Small molecule drug developed by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center. It is currently FDA-approved for Control comparator in clinical trials evaluating hydrocortisone efficacy.
A placebo contains no active pharmaceutical ingredient and produces therapeutic effects solely through the placebo effect—the patient's expectation and psychological response to receiving treatment.
A placebo contains no active pharmaceutical ingredient and produces therapeutic effects solely through the placebo effect—the patient's expectation and psychological response to receiving treatment. Used for Control comparator in clinical trials evaluating hydrocortisone efficacy.
At a glance
| Generic name | Placebo for hydrocortisone |
|---|---|
| Sponsor | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
Placebos are inert substances used as controls in clinical trials to distinguish true drug effects from psychological and contextual factors. In this case, it serves as a comparator to hydrocortisone, a glucocorticoid with immunosuppressive and anti-inflammatory properties. The placebo itself has no direct molecular mechanism but can elicit measurable clinical responses through neurobiological pathways activated by expectation and the clinical context.
Approved indications
- Control comparator in clinical trials evaluating hydrocortisone efficacy
Common side effects
Key clinical trials
- Pilot Study of Aprepitant Effect on Aldosterone Secretion in Diabetic Patient (Diabetes Mellitus) With Hypertension Associated With Low Renin (PHASE2)
- Effect of Supplemental Hydrocortisone During Stress in Prednisolone-induced Adrenal Insufficiency (PHASE4)
- Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2) (PHASE1)
- Plant Protein With Ashwagandha-Rhodiola for Sleep Quality (NA)
- Adjunctive Fludrocortisone in Septic Shock (PHASE2)
- Reiki Breast Surgery QOL Project for Women Undergoing Breast Surgery (NA)
- Poor Sleep During Pregnancy as Risk Factor for Post-partum Stress and Mental Health (NA)
- A Study of Oral Kavalactones Effect on Nurses (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo for hydrocortisone CI brief — competitive landscape report
- Placebo for hydrocortisone updates RSS · CI watch RSS
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center portfolio CI
Frequently asked questions about Placebo for hydrocortisone
What is Placebo for hydrocortisone?
How does Placebo for hydrocortisone work?
What is Placebo for hydrocortisone used for?
Who makes Placebo for hydrocortisone?
What development phase is Placebo for hydrocortisone in?
Related
- Manufacturer: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center — full pipeline
- Indication: Drugs for Control comparator in clinical trials evaluating hydrocortisone efficacy
- Compare: Placebo for hydrocortisone vs similar drugs
- Pricing: Placebo for hydrocortisone cost, discount & access